Courtney Jeffrey 4
4 · Targanta Therapeutics Corp. · Filed Feb 27, 2009
Insider Transaction Report
Form 4
Courtney Jeffrey
Director
Transactions
- Disposition from Tender
Common Stock
2009-02-25−106,149→ 0 total(indirect: See footnote.) - Disposition from Tender
Common Stock
2009-02-25−1,523,210→ 0 total(indirect: See footnote.)
Footnotes (3)
- [F1]The shares were tendered in a tender offer by Boxford Subsidiary Corporation for consideration of (1) $2.00 per common share in cash, plus (2) the contractual right to receive up to an additional $4.55 per common share in contingent cash payments if specified regulatory and commercial milestones are achieved within agreed upon time periods.
- [F2]Shares held by VenGrowth III Investment Fund. Mr. Courtney is a General Partner of VenGrowth III Investment Fund and, as such, may be deemed to hold voting and dispositive power with respect to all shares of common stock held by VenGrowth III Investment Fund. Mr. Courtney disclaims beneficial ownership of the shares held by VenGrowth III Investment Fund except to the extent of his pecuniary interest, if any, in such shares.
- [F3]Shares held by VenGrowth Advanced Life Sciences Fund. Mr. Courtney is a General Partner of VenGrowth Advanced Life Sciences Fund and, as such, may be deemed to hold voting and dispositive power with respect to all shares of common stock held by VenGrowth Advanced Life Sciences Fund. Mr. Courtney disclaims beneficial ownership of the shares held by VenGrowth Advanced Life Sciences Fund except to the extent of his pecuniary interest, if any, in such shares.